Li 2020 [A].
Study characteristics | |||
Patient Sampling | Purpose: Diagnosis of acute‐phase infections Design: Single‐group study estimating sensitivity alone: 49 NAT‐confirmed 2019‐nCoV infected patients (hospitalised patients) Recruitment: Not stated Prospective or retrospective: Not stated Sample size: 49 (49) Further detail: no more details available |
||
Patient characteristics and setting | Setting: hospitalised patients Location: The Fifth Medical Centre of PLA General Hospital of China Country: China Dates: December 2019 to February 2020 Symptoms and severity: 12 (24%) severe; 37 (76%) mild illness; fever (41/49), cough (26/49), fatigue (11/49), dyspnoea (6/49), diarrhoea symptom (0/49); 17 had other systematic diseases (8 hypertension, 5 diabetes, 2 asthma, 1 AIDS, 1 tuberculosis, 1 hepatitis) Demographics: 30, 61% male; median age 43y (IQR: 3 to 79y) Exposure history: 35 patients had been to Wuhan before illness onset or lived in Wuhan city, others had never been to Wuhan recently. Non‐Covid group 1: NA |
||
Index tests | Test name: [A] SP‐based IgG/IgM ELISA; [B] N‐protein based IgG/IgM ELISA Manufacturer: [A] Hotgen Biotech (Beijing, China); [B] Livzon Group (Guangdong, China) Antigen target: [A] S (Spike); [B] N (Nucleocapsid) protein. Evaluation setting: Laboratory Test method: ELISA Timing of samples: Day 2 to 45 pso; 40 samples collected at < 10 days; up to 41 samples > 10 days Samples used: serum Test operator: not reported Definition of test positivity: the S/CO values ≥ 1 considered positive results, < 1 negative Blinding reported: Unclear Threshold predefined: not reported |
||
Target condition and reference standard(s) | Reference standard: NAT; no further details Samples used: not reported Timing of reference standard: Not reported Blinded to index test: yes, reference standard done before index test Incorporated index test: no Definition of non‐COVID cases: NA Samples used: Timing of reference standard: Blinded to index test: Incorporated index test: |
||
Flow and timing | Time interval between index and reference tests: not reported All patients received same reference standard: Yes; all NAT‐tested Missing data: none reported Uninterpretable results: none reported Indeterminate results: none reported Unit of analysis: 206 serum samples from 49 patients |
||
Comparative | |||
Notes | Funding: This work was supported by the Emergency Project for 2019‐nCoV of PLA General Hospital (20EP013). Publication status: Pre‐print Source: Lancet Infectious Diseases Author COI: authors reported no conflict of interest. |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Did the study avoid inappropriate inclusions? | Unclear | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
DOMAIN 2: Index Test (Antibody tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
The reference standard does not incorporate the index test | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Unclear risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Unclear | ||
Did all participants receive a reference standard? | Yes | ||
Were results presented per patient? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |